Characteristics, Treatment and Outcomes of HIV-infected Patients With Malignant Lymphoma: A Registry Study of the European Hematology Association (EHA) Lymphoma Group
Status: Recruiting
Location: See all (6) locations...
Study Type: Observational
SUMMARY
Retrospective und prospective registry on HIV-associated lymphoma. Data on characteristics, type and toxicity of treatment and outcome of patients with HIV-lymphoma will be collected.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Histology or cytology proven non-Hodgkin lymphoma or Hodgkin lymphoma
• HIV-infection at time of lymphoma diagnosis
• Lymphoma diagnosis since 01.01.2010
• Adult patients ≥ 18 years
• Written informed consent
Locations
Other Locations
Germany
University Hospital Cologne
RECRUITING
Cologne
Red Cross Hospital Munich
RECRUITING
Munich
Netherlands
Amsterdam University Medical Centers
NOT_YET_RECRUITING
Amsterdam
Spain
Hospital de la Santa Creu i Sant Pau
RECRUITING
Barcelona
Hospital Universitario de Salamanca
RECRUITING
Salamanca
United Kingdom
University Hospital of Wales
NOT_YET_RECRUITING
Cardiff
Contact Information
Primary
Marcus Hentrich, MD
marcus.hentrich@swmbrk.de
+49 89 1303 4372
Backup
Kai Hübel, MD
kai.huebel@uk-koeln.de
+49 221 478 86177
Time Frame
Start Date: 2021-08-25
Estimated Completion Date: 2029-08-31
Participants
Target number of participants: 300
Related Therapeutic Areas
Sponsors
Leads: Rotkreuzklinikum München gGmbH